Semler Scientific, Inc. (NASDAQ:SMLR) Short Interest Update

Semler Scientific, Inc. (NASDAQ:SMLR) saw a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 1,790,000 shares, a growth of 20.1% from the March 15th total of 1,490,000 shares. Based on an average trading volume of 407,200 shares, the short-interest ratio is presently 4.4 days. Approximately 23.0% of the shares of the stock are short sold.

Hedge Funds Weigh In On Semler Scientific

A number of institutional investors have recently bought and sold shares of the business. BNP Paribas Financial Markets acquired a new position in Semler Scientific in the 4th quarter valued at about $30,000. Jones Financial Companies Lllp acquired a new position in shares of Semler Scientific in the fourth quarter valued at approximately $34,000. Larson Financial Group LLC bought a new position in shares of Semler Scientific during the fourth quarter worth approximately $38,000. NewEdge Advisors LLC increased its stake in shares of Semler Scientific by 318.3% during the fourth quarter. NewEdge Advisors LLC now owns 732 shares of the company’s stock worth $40,000 after purchasing an additional 557 shares during the period. Finally, IFP Advisors Inc acquired a new stake in Semler Scientific during the 4th quarter worth approximately $54,000. Institutional investors and hedge funds own 49.37% of the company’s stock.

Analyst Ratings Changes

Separately, Lake Street Capital upped their price objective on Semler Scientific from $40.00 to $71.00 and gave the company a “buy” rating in a report on Friday, January 24th.

Semler Scientific Price Performance

SMLR traded down $2.48 during trading on Monday, reaching $30.01. The company had a trading volume of 201,737 shares, compared to its average volume of 399,412. Semler Scientific has a 12 month low of $20.88 and a 12 month high of $81.56. The business’s fifty day moving average price is $38.68 and its 200 day moving average price is $45.96. The company has a market cap of $288.01 million, a P/E ratio of 6.11 and a beta of 1.29.

Semler Scientific (NASDAQ:SMLR) last released its earnings results on Tuesday, February 18th. The company reported $3.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.20 by $3.21. Semler Scientific had a return on equity of 50.77% and a net margin of 72.65%. The business had revenue of $12.41 million for the quarter.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.